Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced clinical data on adipose tissue distribution in non-diabetic patients treated with sotagliflozin will be presented at the 22nd Global Cardio ...
In its latest PFDD installment, the FDA offers a detailed roadmap for sponsors seeking to design, adapt, or validate COAs that accurately ...
Post-hoc analysis of RAP-219 Phase 2a data showed early onset of action and consistency of median response over the entire ...
A retrospective real-world study strengthens evidence that early, sustained treatment with the antiamyloid lecanemab can slow ...
Clene is planning to submit an application to the FDA in early 2026 requesting the accelerated approval of CNM-Au8 for ALS.
Fulcrum Therapeutics To Host Investor Event To Review New Clinical Data From The PIONEER Trial Of Pociredir In Sickle Cell Disease On December 7, 2025. CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) ...
The launch of a new accessible membership tier and a 47-state clinical expansion strengthen Geviti’s infrastructure for ...
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...
The cancer center’s first test of the technology matched all of its manually identified clinical trials candidates and found ...
AWS also introduced the Trainium 3 chip and new AI-optimised servers designed to handle resource-intensive healthcare ...
The technology is designed to help thousands of diabetic and hypertensive patients achieve control over their conditions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback